Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMX | P51813 | 2/20 | 0.53 |
| ▸ | FLT3 | P36888 | 6/20 | 0.50 |
| ▸ | TYMS | P04818 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12439612 | 0.81 | FLT3 (0.47) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18033193 | 0.76 | FLT3 (0.67) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18033282 | 0.76 | FLT3 (0.54) | BMXFLT3ALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL18033260 | 0.75 | FLT3 (0.53) | BMXFLT3ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL18033154 | 0.74 | FLT3 (0.50) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18033196 | 0.74 | FLT3 (0.55) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL31346231 | 0.74 | BMX (0.58) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18033232 | 0.73 | FLT3 (0.57) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18033172 | 0.72 | FLT3 (0.50) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18033105 | 0.72 | FLT3 (0.50) | BMXFLT3ALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110178107-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2011-07-21 | — | — | US | disclosed |
| US-20110178107-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178107-A1 | HCV PROTEASE INHIBITORS | HAVCR2, RNASE1, SERPINB1 | BMX 3368/4885FLT3 3614/4885TYMS 4035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.